LANGE LOUIS G
Insider CIK 1238401 · NONE Director · MAXY Director · ESPR Director · BOLD Director · NAMS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-03-11 | 2026-03-12 | 44,173 | $30.41 | $1.34M | 10,806 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-03-11 | 2026-03-12 | 446 | $31.23 | $13.9K | 10,360 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | X Exercise deriv | 2026-03-09 | 2026-03-10 | 44,619 | — | $0 | 0 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | X Exercise | 2026-03-09 | 2026-03-10 | 44,619 | $11.50 | $513.1K | 54,979 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2026-03-06 | 2026-03-10 | 28,186 | $29.41 | $829.0K | 0 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2026-01-07 | 2026-01-09 | 15,300 | — | $0 | 15,300 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award | 2026-01-07 | 2026-01-09 | 3,400 | — | $0 | 10,360 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2025-06-01 | 2025-06-03 | 68 | — | $0 | 0 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2025-06-01 | 2025-06-03 | 68 | — | $0 | 28,186 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2025-05-01 | 2025-05-02 | 69 | — | $0 | 68 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2025-05-01 | 2025-05-02 | 69 | — | $0 | 28,118 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2025-04-14 | 2025-04-21 | 69 | — | $0 | 137 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2025-04-14 | 2025-04-21 | 69 | — | $0 | 28,049 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise deriv | 2025-03-26 | 2025-03-28 | 3,102 | — | $0 | 206 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2025-03-26 | 2025-03-28 | 3,308 | — | $0 | 3,308 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | M Exercise | 2025-03-26 | 2025-03-28 | 3,102 | — | $0 | 10,062 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award | 2025-01-07 | 2025-01-08 | 6,960 | — | $0 | 6,960 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2025-01-06 | 2025-01-08 | 32,500 | — | $0 | 32,500 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | P Buy | 2024-02-13 | 2024-02-21 | 5,000 | $19.00 | $95.0K | 24,878 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | A Award deriv | 2024-01-01 | 2024-01-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 32,343 | $60.00 | $1.94M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 13,678 | $60.00 | $820.7K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 265,799 | $60.00 | $15.95M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 3,555 | $60.00 | $213.3K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-12-23 | 2019-12-27 | 1,000 | $59.60 | $59.6K | 13,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-12-23 | 2019-12-27 | 10,000 | $59.60 | $596.0K | 265,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-09-23 | 2019-09-25 | 9,755 | $32.15 | $313.6K | 276,044 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-09-23 | 2019-09-25 | 1,000 | $32.18 | $32.2K | 14,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-09-23 | 2019-09-25 | 245 | $32.66 | $8.0K | 275,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-06-24 | 2019-06-26 | 600 | $40.00 | $24.0K | 285,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-06-24 | 2019-06-26 | 15,798 | $37.60 | $594.0K | 290,001 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-06-24 | 2019-06-26 | 800 | $37.89 | $30.3K | 15,878 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-06-24 | 2019-06-26 | 200 | $39.46 | $7.9K | 15,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-06-24 | 2019-06-26 | 3,602 | $38.15 | $137.4K | 286,399 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-03-25 | 2019-03-27 | 300 | $36.64 | $11.0K | 305,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-03-25 | 2019-03-27 | 1,000 | $36.00 | $36.0K | 16,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-03-25 | 2019-03-27 | 558 | $35.94 | $20.1K | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2019-03-25 | 2019-03-27 | 19,700 | $35.99 | $709.0K | 306,099 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 16,200 | — | $0 | 16,200 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-12-24 | 2018-12-27 | 10,000 | $18.50 | $185.0K | 32,343 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-12-24 | 2018-12-27 | 20,000 | $18.67 | $373.4K | 325,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-12-24 | 2018-12-27 | 1,000 | $18.70 | $18.7K | 17,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-12-24 | 2018-12-27 | 1,000 | $18.71 | $18.7K | 558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-11-15 | 2018-11-16 | 20,000 | $22.49 | $449.8K | 345,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-11-15 | 2018-11-16 | 4,000 | $22.49 | $90.0K | 3,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-09-24 | 2018-09-26 | 1,000 | $37.25 | $37.3K | 7,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-09-24 | 2018-09-26 | 1,000 | $37.27 | $37.3K | 18,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-09-24 | 2018-09-26 | 19,800 | $37.35 | $739.5K | 365,999 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-09-24 | 2018-09-26 | 200 | $37.76 | $7.6K | 365,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-09-24 | 2018-09-26 | 10,000 | $37.45 | $374.5K | 42,343 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-09-24 | 2018-09-26 | 1,000 | $37.27 | $37.3K | 1,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 9,790 | $40.86 | $400.0K | 52,553 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 100 | $41.47 | $4.1K | 2,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 18,860 | $40.36 | $761.2K | 386,939 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 1,140 | $41.31 | $47.1K | 385,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 1,000 | $40.78 | $40.8K | 8,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 100 | $41.46 | $4.1K | 19,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 900 | $40.79 | $36.7K | 19,778 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 900 | $40.74 | $36.7K | 2,658 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-06-25 | 2018-06-27 | 210 | $41.27 | $8.7K | 52,343 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-06-08 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 500 | $28.28 | $14.1K | 10,055 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 517 | $28.32 | $14.6K | 4,041 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 400 | $29.57 | $11.8K | 20,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 600 | $28.38 | $17.0K | 21,078 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 500 | $29.46 | $14.7K | 9,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 483 | $29.57 | $14.3K | 3,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 1,732 | $29.95 | $51.9K | 405,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 6,700 | $29.57 | $198.1K | 407,531 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 11,568 | $29.00 | $335.5K | 414,231 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 6,600 | $29.27 | $193.2K | 62,343 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2018-03-26 | 2018-03-28 | 18,400 | $28.35 | $521.6K | 68,943 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-12-22 | 2017-12-26 | 15,000 | $30.88 | $463.2K | 425,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-12-22 | 2017-12-26 | 1,000 | $30.90 | $30.9K | 10,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-12-22 | 2017-12-26 | 1,000 | $30.86 | $30.9K | 21,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-12-22 | 2017-12-26 | 1,000 | $30.87 | $30.9K | 4,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-10-08 | 2017-10-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 4,244 | $28.31 | $120.1K | 441,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 756 | $29.32 | $22.2K | 440,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 1,700 | $28.12 | $47.8K | 11,855 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 1,800 | $28.14 | $50.7K | 22,878 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 200 | $29.24 | $5.8K | 22,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 1,800 | $28.14 | $50.7K | 5,758 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 200 | $29.25 | $5.8K | 5,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 300 | $29.26 | $8.8K | 11,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 359 | $28.88 | $10.4K | 7,558 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 400 | $28.89 | $11.6K | 13,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 600 | $27.99 | $16.8K | 13,955 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 7,594 | $28.76 | $218.4K | 445,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 7,406 | $27.85 | $206.3K | 453,393 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 641 | $28.07 | $18.0K | 7,917 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 364 | $28.85 | $10.5K | 24,678 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-25 | 2017-09-26 | 636 | $28.06 | $17.8K | 25,042 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-06-26 | 2017-06-28 | 2,824 | $19.52 | $55.1K | 467,975 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-06-26 | 2017-06-28 | 7,176 | $20.59 | $147.8K | 460,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-06-26 | 2017-06-28 | 5,000 | $18.76 | $93.8K | 470,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2016-08-24 | 2016-08-25 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 9,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 13,400 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 2,233 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 2,233 | — | $0 | 14,555 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 9,000 | — | $0 | 475,799 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 13,400 | — | $0 | 87,343 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-06-24 | 2015-06-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-01-07 | 2015-01-08 | 9,000 | — | $0 | 9,000 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2014-01-06 | 2014-01-08 | 21,260 | — | $0 | 21,260 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2014-01-15 | 12,972 | — | $0 | 12,972 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 122 | — | $0 | 122 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 122 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 455 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 455 | — | $0 | 455 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 3,144 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 3,144 | — | $0 | 3,144 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-10-31 | 2013-11-01 | 25,653 | — | $0 | 25,653 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 186,989 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 14,314 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 51,230 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 7,333 | — | $0 | 7,333 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 10,714 | $14.00 | $150.0K | 197,703 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 186,989 | — | $0 | 186,989 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 14,314 | — | $0 | 14,314 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 3,500 | $14.00 | $49.0K | 17,814 | SEC↗ |
| MAXY MAXYGEN INC | A Award | 2012-06-06 | 2012-06-07 | 10,000 | — | $0 | 60,000 | SEC↗ |